Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
Clinical trial NCT01378117 · COMPLETED
Trial details
- NCT number
- NCT01378117
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-05-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.